150 State St., Albany,
NY, USA, 12207
Microencapsulation is a process in which tiny particles or droplets of liquid, solid or gaseous materials are surrounded by a coating on a micro metric scale to give small capsules, with advantageous properties. The microcapsule may even have multiple walls. This enclosed material in the microcapsule is referred to as the core, internal phase, or fill, whereas the wall is sometimes called a shell, coating, or membrane. The coating materials generally used for coating are: Ethyl cellulose, polyvinyl alcohol, Gelatin, Polysaccharides and Sodium alginate.
The process of microencapsulation can be executed by different techniques such as spray, emulsion, and dripping depending upon the shape, size, and chemical properties of the core material.
These technologies are utilized for various purposes, which include isolation of core from its surroundings, improving the handling properties of a sticky material, controlled release of drugs, safe handling of toxic materials, masking the taste, odor or activity of the core, etc and are broadly used by several end-user industries including pharmaceutical, food and feed, home and personal care, industrial and chemical, agriculture, and others.
Many bioactive substances are unstable and easily deteriorate in capsules, tablets, nutrient bars and other food systems; microencapsulation helps increase the stability and life of these products.
The global microencapsulation market is poised to grow at a steady CAGR in the upcoming years.
The growth of this market is attributed towards major relying factors including; the growing acceptance and increasing applications of microencapsulated products across various industry verticals, the prevalence of various health disorders and inclination of consumers towards healthier lifestyles, the growing demand for pharmaceutical and agrochemical products, the increasing use of the technology in masking taste, odor and activity of encapsulated materials , the surging awareness regarding the benefits of microencapsulated medicinal capsules and dietary supplements and the increase in demand for fortified food products with health benefits etc.
Additionally, microencapsulation is extensively used in the healthcare and pharmaceutical sector for controlled drug delivery. Also, pharmaceutical companies use this technology to mask the bitter taste or smell in drugs and to provide targeted delivery and controlled delivery. Increasing demand of controlled release systems and increasing advancements by major pharmaceutical players for development of advanced protective technology for drug delivery application are driving the growth of global microencapsulation market.
Moreover, scope for advancements in the upcoming fields such as phase change materials (PCM) to incorporate them in sports equipment, building materials, and textiles is expected to bolster the product demand comprehensively.
Furthermore, growing need to enhance product functionality, rising popularity of functional foods, rise in disposable income across developing countries, increasing collaborations and growing investments in technology development and R&D activities and reduction in capsule size coupled with increasing bioavailability are expected to further contribute to the growth of this market.
However, high cost of processing such technologies and research & development resources, increasing competition for basic raw material, the availability of substitutes and the increasing demand for nano-encapsulation technology are factors that are restraining the growth of this market.
At this time, major suppliers in this market have their manufacturing facilities spread all across the world. And, though the COVID-19 outbreak has impacted their businesses as well, there is no significant impact on the global operations and supply chain of their microencapsulation products. Multiple manufacturing facilities of players are still in operation and running quite smoothly.
MICROENCAPSULATION MARKET SEGMENTATION:
By Core Material:
By Shell Material:
By End-Use Industry:
The North American region is currently dominating the microencapsulation market and is expected to continue to foster robust growth in the coming years also and maintain its position thereof. The growth in the region can be attributed towards factors such as the growing demand and awareness about value-added products, growth in the pharmaceutical, food & beverage and other industries coupled with the high product demand for application in these industries, the growing innovations in the textile industry, surging investments in the end-use industries, the presence of major manufacturers operating in the countries in the region etc. The U.S. is the major contributor in the region.
The European region is the second largest regional market for microencapsulation technologies and is anticipated to witness substantial growth in the years to come owing to the increasing demand from the food & beverage sector, the presence of major pharmaceutical manufacturers, the early adoption of the this technology in end-use applications and the development of novel drug delivery systems in the region etc. The U.K., Germany, Italy, and France are the major contributors in the region.
The Asia Pacific region is the fastest growing regional market for microencapsulation technology and is projected to also continue to grow at a massive rate in the next few years. This is due to factors such as the rapid expansion of the end-use industries across the region along with the increasing demand of the technology in those industries, the increasing favorable government policies to promote FDI in the pharmaceutical industry in the emerging economies of the region, the increasing government expenditure on healthcare sector, the presence of major manufacturers etc. Additionally, technological advancements and rapid industrialization in the region are also contributing to the growth of this market. The major contributors in the region are India and China.
FEW KEY PLAYERS IN MICROENCAPSULATION MARKET:
In July 2020, Bionema Ltd., a leading U.K.-based biotechnology company received a grant from Innovate UK to support the company’s continual development of its bioinsecticide microencapsulation formulation, which is said to deliver an effective alternative to chemical pesticides.
In October 2020, Lubrizol Life Science Health (LLS Health) launched ASTAGIL microcapsules, its new sustainable, organic-certified, astaxanthin (Haematococcus pluvialis), microencapsulated with spirulina. The two ingredients was said to be uniquely combined in a patent-pending product designed to promote mental agility and support healthy ageing for young and senior adults.
Timeline Considered for Analysis:
- 2019: Base Year
- 2020 to 2025: Forecast Period
Research Scope and Deliverables
Overview & Executive Summary
Market Drivers, Trends, Challenges and Opportunities
Market Size and Forecast Projections
Macroeconomic Indicators of Various Countries Impacting the Growth of the Market
Extensive Coverage of Industry Players including Recent Product Launches and Market Activities
Porter’s Five Force Analysis
Market Segmentation Analysis:
Industry report analyzes the global microencapsulation market by the following segments:
Customization: We also offers customization’s in the industry report as per the company’s specific needs.
Key Questions Answered in the Global Microencapsulation Industry Report
The report offers a comprehensive insight on the Microencapsulation Market share, competitor landscape, market trends, growth, revenue, and key driver’s analysis with coverage of key players, top geographies, product types and end user.
Exhaustive secondary research and in-depth primary interviews with industry experts has been conducted to present qualitative and quantitative insights in the report.
We offer customizations as per client’s specific needs.